On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Krankenhaus Barmherzige Brüder

InstitutionResearch output, impact & collaborations

Krankenhaus Barmherzige Brüder is a institution indexed in ScholarIQ from OpenAlex.

What is known about Krankenhaus Barmherzige Brüder?

ScholarIQrecord summary

Krankenhaus Barmherzige Brüder is a research organisation in Regensburg, DE. OpenAlex records 3,438 works and 101,421 citations for it. 861 researchers list it as their most recent affiliation.

How many works does Krankenhaus Barmherzige Brüder have?

ScholarIQindexed works

Krankenhaus Barmherzige Brüder has 3,438 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Krankenhaus Barmherzige Brüder have?

ScholarIQcitation count

Krankenhaus Barmherzige Brüder has 101,421 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Krankenhaus Barmherzige Brüder?

ScholarIQresearcher count

Krankenhaus Barmherzige Brüder has 861 researchers in the ScholarIQ index.

What is the average h-index at Krankenhaus Barmherzige Brüder?

ScholarIQavg h-index

Krankenhaus Barmherzige Brüder has an average h-index of 23.5 in OpenAlex.

What is the ROR of Krankenhaus Barmherzige Brüder?

ScholarIQror

The ROR for Krankenhaus Barmherzige Brüder is on the source record.

What is the OpenAlex record for Krankenhaus Barmherzige Brüder?

ScholarIQopenalex

The OpenAlex for Krankenhaus Barmherzige Brüder is on the source record.

Who are the most-cited researchers behind Krankenhaus Barmherzige Brüder?

ScholarIQtop researchers by citations
1
Markus Steinbauer · Aortic aneurysm repair treatments
161 works4,710 citations
2
I. Töpel · Infectious Aortic and Vascular Conditions
65 works991 citations

What are the most-cited papers on Krankenhaus Barmherzige Brüder?

ScholarIQmost cited works
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
Markus Guba, Philipp von Breitenbuch, Markus Steinbauer, Gudrun E. Koehl, Stefanie Flegel, Matthias Hornung, Christiane J. Bruns, Carl Zuelke, Stefan Farkas, Matthias Anthuber, Karl‐Walter Jauch, Edward K. Geissler
Nature Medicine. 20021,738 Citations
RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICE
Gudrun E. Koehl, Joachim Andrassy, Markus Guba, Sebastian Richter, Alexander Kroemer, Marcus N. Scherer, Markus Steinbauer, Christian Graeb, Hans J. Schlitt, Karl‐Walter Jauch, Edward K. Geissler
Transplantation. 2004222 Citations
Comparison of Outcomes With Open, Fenestrated, and Chimney Graft Repair of Juxtarenal Aneurysms: Are We Ready for a Paradigm Shift?
Αthanasios Katsargyris, Kyriakos Oikonomou, Chris Klonaris, I. Töpel, Eric L.G. Verhoeven
Journal of Endovascular Therapy. 2013221 Citations
Endovascular repair of proximal endograft collapse after treatment for thoracic aortic disease
Markus Steinbauer, Alexander Stehr, Karin Pfister, Thomas Herold, Niels Zorger, I. Töpel, Christian Paetzel, Piotr M. Kasprzak
Journal of Vascular Surgery. 2006125 CitationsOPEN ACCESS
Kinetics of White Blood Cell Staining by Intravascular Administration of Rhodamine 6G
H. Baatz, Markus Steinbauer, A. G. Harris, Fritz Krombach
International Journal of Microcirculation. 2008121 Citations

How much of the research on Krankenhaus Barmherzige Brüder is open access?

ScholarIQopen access share
25%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
0%
Bronze
17%
Closed
75%

Related on ScholarIQ

470M+ articles · 14-day free trial